Laxai Pharma, Ltd.
Limited financial coverage for LAXAF.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Laxai Pharma, Ltd. is an American company that offers specialized contract research services. The firm provides extensive support throughout the entire pharmaceutical development process.
- CEO
- J. Ram Ajjarapu
- IPO
- 1994
- Employees
- 1
- HQ
- Tampa, FL, US
Get TickerSpark's AI analysis on LAXAF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.45
- RSI (14)
- 0
- Avg Volume
- 3
No earnings-call transcripts are available for LAXAF yet.
- Free Float
- 0.0%
- Shares Outstanding
- 4.75B
- Float Shares
- 0
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 18, 11 | UTA Capital LLC | other | 16,800,000 |
| Jul 1, 10 | UTA Capital LLC | other | 7,820,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our LAXAF coverage
Recent articles, reports, and earnings notes.
No research on LAXAF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LAXAF report →